Yongxiang Zhao | Gene Therapy | Best Researcher Award

Yongxiang Zhao | Gene Therapy | Best Researcher Award

Prof. Dr Yongxiang Zhao,Guangxi Medical University,China

Prof. Dr. Yongxiang Zhao, Director of the State Key Laboratory of Targeted Oncology, is a renowned expert in tumor diagnosis and treatment. A recipient of the Ho Leung Ho Lee Award 🏆 and a leader in the Yangtze River Scholars Award Program, he pioneered the world’s first gene-edited liver cancer monkey model 🧬 and developed the first intravenous recombinant NDV oncolytic virus 🦠, showing a 90% disease control rate in Phase III trials. With over 160 SCI papers 📄 and 46 invention patents, he has led 30+ major drug development projects, shaping the future of cancer therapy. 🚀

Publication Profile

Scopus

Outstanding Leadership and Recognition

Prof. Dr. Yongxiang Zhao 🎓 is a globally renowned researcher and a visionary leader in the scientific community. As the Director of the State Key Laboratory of Targeted Oncology 🏥, he has spearheaded groundbreaking advancements in cancer research. His outstanding achievements have earned him prestigious honors, including the Ho Leung Ho Lee Award 🏆. Additionally, he leads national innovation programs such as the Yangtze River Scholars Award Program Innovation Team 🌊 and the Ten Thousand Talents Program 🌟. These recognitions underscore his influential role in shaping the future of scientific discovery and fostering innovation on a national and international scale.

Contributions to Oncology

Prof. Dr. Yongxiang Zhao 🎓 has made groundbreaking contributions to oncology, particularly in targeted tumor diagnosis and treatment. He pioneered the development of the world’s first gene-edited liver cancer monkey model 🧬🐒, a revolutionary advancement that has transformed cancer research. This innovative model provides an exceptionally accurate system for studying liver cancer, paving the way for more effective treatment strategies 💊. His work has significantly enhanced our understanding of tumor progression and therapeutic interventions, solidifying his reputation as a leader in oncology 🔬. Through his pioneering research, Dr. Zhao continues to drive innovation and shape the future of cancer treatment.

Breakthrough Innovations in Cancer Treatment

Prof. Dr. Yongxiang Zhao 🎓 has achieved a groundbreaking milestone in cancer treatment with the development of the world’s first intravenous recombinant Newcastle Disease Virus (NDV) oncolytic virus 🦠💉. This revolutionary therapy targets 13 advanced cancers, including liver cancer, offering a promising new approach to oncology. Multi-center clinical trials demonstrated an impressive Disease Control Rate (DCR) of 90% 📊, leading to Phase III clinical trials. This breakthrough has the potential to transform cancer therapy, providing new hope to patients worldwide 🌍. Dr. Zhao’s innovative work continues to push the boundaries of medical science, redefining the future of cancer treatment.

Extensive Research and Intellectual Property

Prof. Dr. Yongxiang Zhao 🎓 is a prolific researcher whose contributions have profoundly impacted oncology and drug development. With over 160 SCI publications 📄, including influential papers in top-tier journals like Cell 🧬, his work has advanced scientific understanding in the field. His innovative mindset is reflected in 46 invention patents 🏅, highlighting his role as a pioneer in medical research. Leading over 30 major national drug development projects 💊, Dr. Zhao has played a crucial role in translating groundbreaking discoveries into real-world medical applications, shaping the future of cancer treatment and improving patient outcomes globally 🌍.

Research Focus

Dr. Yongxiang Zhao’s research primarily focuses on nanomedicine, drug delivery systems, and cancer therapeutics. His work spans polymeric nanoparticles 🧪, exosomal RNA therapies 🧬, and aptamer-based antiviral strategies 🦠, particularly targeting multidrug-resistant bacterial infections and cancer treatment 🎗️. He also explores biocompatible microspheres for tissue repair 🏥 and oncology-focused biomaterials. His research integrates biomedical engineering 🏗️, molecular biology 🧫, and clinical applications. Dr. Zhao’s contributions extend to tumor microenvironment studies, cancer-associated fibroblasts 💊, and immunotherapeutic bacteria 🦠 for precision medicine, making significant strides in advanced therapeutics and biomaterials development.

Publication Top Notes

Moxifloxacin-Loaded Polymeric Nanoparticles for Overcoming Multidrug Resistance in Chronic Pulmonary Infections Caused by Pseudomonas aeruginosa

The function of albumin and its application in tumor therapy

Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity

Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies

Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis

Correction to: Engineering a precise adenine base editor with minimal bystander editing (Nature Chemical Biology, (2023), 19, 1, (101-110), 10.1038/s41589-022-01163-8)

Polymer Microspheres and Their Application in Cancer Diagnosis and Treatment

Microalgae-loaded biocompatible alginate microspheres for tissue repair

Landscape of global urban environmental resistome and its association with local socioeconomic and medical status

Oncolytic mineralized bacteria as potent locally administered immunotherapeutics

Berat Cinar Acar | Biopharmaceutics | Best Researcher Award

Berat Cinar Acar | Biopharmaceutics | Best Researcher Award 

Dr Berat Cinar Acar,Department of Biology,Turkey

🔬 Dr. Berat Çınar Acar is a dedicated biologist specializing in microbiology and environmental biotechnology. He earned his Ph.D. in Biology from Gazi University (2018), focusing on bioremediation of chromium in industrial wastewater. His M.Sc. (2012) explored β-glucosidase enzyme activity in Lactobacillus and Bifidobacterium species. Currently a lecturer at Gazi University, he has led and contributed to multiple scientific research projects on microbial biotechnology and environmental detoxification. His research advances sustainable solutions for pollution control and microbial enzyme applications. 🌍🧪

Publication Profile

google scholar

Education Information

Dr. Berat Cinar Acar 🎓 earned his Ph.D. in Biology from Gazi University’s Institute of Science on May 30, 2018. His doctoral research focused on beta-glucosidase enzyme activity and isoflavone hydrolysis in Lactobacillus and Bifidobacterium under the supervision of Assoc. Prof. Zehra Nur Yüksekdağ. He completed his M.Sc. in Biology at Gazi University in 2012 and obtained his B.Sc. in Biology from Niğde University in 2008. With a strong academic background, he currently serves as a Lecturer in the Department of Biology at Gazi University, contributing to research and education in the field of microbiology 🔬.

Academic Duties

Dr. Berat Çınar Acar is a dedicated faculty member 🏫 at Gazi University, Faculty of Science, Department of Biology, specializing in the field of biology 🔬. As a lecturer, he plays a vital role in academic research and education, guiding students in various biological disciplines 📚. His expertise spans microbiology, biotechnology, and environmental sciences, contributing to innovative studies on probiotics, enzyme activities, and bioremediation 🌱🦠. Dr. Acar’s commitment to scientific advancement and education continues to inspire future researchers and professionals, fostering a deeper understanding of biological sciences for sustainable solutions to global challenges. 🌍

Awards

Dr. Berat Cinar Acar 🏆 was honored with the Gazi University Rectorate Incentive Award in 2024 for his outstanding contributions to scientific research and academic excellence. This prestigious recognition highlights his dedication to advancing biological sciences and his impactful work in microbiology 🔬. As a distinguished academic at Gazi University, Dr. Acar continues to inspire students and researchers through his innovative studies and commitment to education 📚. His achievements reflect his passion for scientific discovery and his ongoing efforts to push the boundaries of knowledge in his field.

Certificate

Dr. Berat Cinar Acar 📜 has earned multiple prestigious certifications, showcasing his expertise in advanced scientific techniques. In 2023, he received Mikrobiyota Education and Real-Time PCR Training Certificates 🧬 from Krosgen. His international certification in ICP-OES OPTIMA (2017) reflects his proficiency in analytical instrumentation 🔬. Additionally, he completed the Oba Chemometrics Training in Antalya (2015) and gained expertise in GC-MS instrumentation and ChemStation software from Agilent Technologies in Ankara (2012). These certifications highlight his dedication to continuous learning and innovation in microbiology, biotechnology, and analytical sciences 🏅

Works

Dr. Berat Çınar Acar is an esteemed researcher with significant contributions to microbiology, nanotechnology, and environmental science 🧪🌍. His work spans antimicrobial activity, bioremediation, and probiotic research, with publications in top-tier journals like Microscopy Research and Technique and Water, Air, and Soil Pollution 📖🔬. He has explored green synthesis of silver nanoparticles, cold plasma applications for food safety, and bioreduction of heavy metals. His international conference presentations showcase innovations in probiotic enzyme activity and biosurfactants 🦠🛡️. Dr. Acar’s research advances biotechnology and public health, addressing critical environmental and food safety challenges. 🚀

Duties Performed in Projects

Dr. Berat Çınar Acar has contributed significantly to various scientific research projects, focusing on microbiology, biotechnology, and environmental sciences 🧪🌱. His work includes chromium detoxification via bioremediation, probiotic bacterial studies, and beta-galactosidase enzyme activity analysis. He has led projects on cold atmospheric plasma applications for pathogen inactivation, biosorption techniques, and the antibacterial properties of hydrogels infused with silver nanoparticles. Additionally, Dr. Acar investigates extracellular polysaccharide production in probiotic strains and the bactericidal effects of ozone and plasma treatments against clinical pathogens 🦠🔬. His research continues to advance sustainable and innovative scientific solutions for health and the environment. 🌍✨

Research Focus

Dr. Berat Çınar Acar specializes in microbiology 🦠, probiotics 🥛, enzyme activity 🧪, and environmental biotechnology 🌱. His research focuses on probiotic bacteria, particularly Lactobacillus and Bifidobacterium species, exploring their β-glucosidase and β-galactosidase enzyme activities. He also investigates bioremediation for heavy metal removal and the biological cementation of soils. Additionally, his work extends to antimicrobial activities 🔬, folate production, and nanotechnology-based green synthesis 🌿⚗️. His studies contribute to food biotechnology, environmental sustainability, and innovative biomedical applications, making his research crucial for human health, nutrition, and ecological balance.

Publication Top Notes

Probiotic properties of lactobacilli species isolated from children’s feces

β-Glucosidase activity and bioconversion of isoflavone glycosides to aglycones by potential probiotic bacteria

Cementation in a matrix of loose sandy soil using biological treatment method

Beta-Glycosidase Activities of Lactobacillus spp. and Bifidobacterium spp. and The Effect of Different Physiological Conditions on Enzyme Activity

Kimyasal yöntemlerle atık sulardan ağır metal giderimi

Investigation of Chromium (III) Adsorption on Acid-Treated Bentonite Evaluation of Kinetic/Thermodynamic Data

Bioreduction of Cr(VI) by Raoultella ornithinolytica BCA13 Obtained from Tannery Effluent

Lactobacillus cinsi bakteriler tarafından üretilen biyosürfektanların anti-biyofilm ve anti-mikrobiyal aktivitelerinin belirlenmesi

Analyzing antimicrobial activity of ZnO/FTO, Sn–Cu‐doped ZnO/FTO thin films: Production and characterizations

Lactobacillus ve bifidobacterium cinsi bakterilerin beta-glukozidaz enzim aktivitesi ve izoflavon hidrolizi

Francesco Ceppa | Precision Medicine | Excellence in Research

Francesco Ceppa | Precision Medicine | Excellence in Research

Dr Francesco Ceppa,Università cattolica del sacro cuore,Italy

Dr. Francesco Ceppa 👨‍⚕️Born on May 15, 1994, in Pescara, Italy 🇮🇹, Dr. Francesco Ceppa is a dedicated medical professional specializing in Emergency Medicine at the prestigious A. Gemelli Hospital, Università Cattolica del Sacro Cuore 🏥. A graduate in Medicine and Surgery 🎓 (2020), he has excelled with advanced certifications like Advanced Life Support (ALS) 🩺. Dr. Ceppa gained invaluable experience as a COVID-19 vaccinator and through clinical roles in emergency medicine and abdominal surgery. Fluent in Italian 🇮🇹 and proficient in English 🌍, he combines excellent interpersonal 🤝, organizational 📋, and technical skills 💻 to advance patient care.

Publication Profile

orcid

 Academic Background

Dr. Francesco Ceppa is a dedicated medical professional who graduated from the Università Cattolica del Sacro Cuore with a degree in Medicine and Surgery, earning an impressive score of 101/110 🎓. His strong academic foundation is complemented by an outstanding high school diploma 📚 and proficiency in English at the C1 level 🌍. In line with his commitment to excellence in healthcare, Dr. Ceppa obtained an Advanced Life Support (ALS) certification in 2022 🩺, equipping him to handle critical medical situations with expertise. His achievements highlight his passion for advancing his skills and making a meaningful impact in the field of medicine. 💡✨

Professional Experience

Dr. Ceppa has showcased exceptional expertise through various impactful roles. 💉 During the COVID-19 pandemic, he actively contributed to public health by participating in antigen testing and vaccination campaigns. 🩺 His journey in Emergency Medicine began with a residency at the renowned Agostino Gemelli University Hospital, highlighting his commitment to critical care and acute medical settings. 🚨 Additionally, Dr. Ceppa has been involved in clinical collaborations with key departments, including surgery and translational medicine, fostering interdisciplinary connections that may pave the way for groundbreaking research. 🔬 His dedication exemplifies a blend of hands-on care and forward-thinking innovation. 🌟

Research Contributions

Dr. Francesco Ceppa is a dedicated medical professional with exceptional expertise in emergency medicine, holding an Advanced Life Support (ALS) certification 🩺. Renowned for his technical proficiency, he is rated “excellent” in utilizing medical equipment and computer systems for efficient healthcare delivery 💻. His outstanding teamwork and organizational skills 🤝 ensure seamless collaboration in research and clinical settings. However, his CV lacks explicit mention of peer-reviewed publications, conference presentations, research grants, or independent projects, as well as specific contributions to advancing medical science or methodologies. Strengthening these areas could further highlight his impact and expertise in the medical field. 📚✨

Nermin Fayed | Nanomedicine | Excellence in Research

Nermin Fayed | Nanomedicine | Excellence in Research

Dr Nermin Fayed, Forensic Medicine and clinical toxicology faculty of medicine Cairo University, Egypt

Dr. Nermin Fayed is a highly skilled physician and academic with a Ph.D. in Forensic and Clinical Toxicology from Cairo University (2018) 🩺📚. Currently a lecturer at Kasr Al-Aini, Faculty of Medicine, Cairo University, he specializes in forensic medicine, clinical toxicology, and medical ethics, teaching both undergraduate and postgraduate students. With extensive experience in patient care, research, and publishing internationally, his work includes pioneering contributions like brain fingerprinting 🧠🔬. A coordinator and forensic consultant at the Safe Women Unit, he is dedicated to advancing toxicology education and supporting vulnerable populations. Fluent in Arabic, English, and French, he bridges medical expertise and community service 🌍.

Publication Profile

Scopus

Education Qualification

Dr. Nermin Fayed holds a Ph.D. in Forensic and Clinical Toxicology from the Faculty of Medicine, Cairo University (January 2018), following her Master’s degree in the same field (October 2014). She earned her M.B.B.Ch in Medicine and General Surgery with honors from Cairo University in November 2007. 🩺🎓 Dr. Fayed is certified under Egyptian Medical License No. 198519. Fluent in Arabic 🇪🇬, her native language, she excels in English 🌐 (reading, speaking, writing) and has a fair command of French 🇫🇷. Her expertise and multilingual abilities make her a distinguished professional in the medical and toxicology field.

Academic Appointments

Dr. Nermin Fayed is a dedicated Lecturer at the Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Cairo University, since January 2018. Her responsibilities include teaching forensic medicine, clinical toxicology, and medical ethics to undergraduate and postgraduate students, both in mainstream and non-Arabic programs. She actively engages students through tutorials, problem-based learning, and simulation labs 🧑‍⚕️📚. Dr. Fayed supervises practical exams, monitors student activities, and contributes to curriculum development. She has published internationally on brain fingerprinting in concealed information detection 🧠📄 and presented at global conferences. Additionally, she played a pivotal role in exam oversight and grade verification for Cairo University students. 🌍📖

Experience

Between 2015 and 2017, extensive rotations were completed in various specialties, including Surgery, Pediatrics, Internal Medicine, Ob/Gynecology, Emergency Medicine, Anesthesia, Dermatology, and Audiology. 🌟 Additionally, responsibilities included coordinating internal control for the Forensic Medicine and Clinical Toxicology department. From 2019 to 2020, duties expanded to coordinating external control for undergraduate exams, including monitoring, reviewing, and grading. 📋 From 2019 to 2021, lecturing in Forensic Medicine at Kasr Al Aini’s integrated program (IPKA) commenced. Currently, as a forensic consultant at the Safe Women Unit and lecturer, responsibilities include teaching, supervising exams, and coordinating schedules for medical students. 👩‍⚕️📚

Teaching Experience

Dr. Nermin Fayed is a dedicated educator and specialist in Forensic Medicine and Clinical Toxicology at Cairo University’s Faculty of Medicine. Since 2018, she has been teaching practical courses and lectures to 3rd and 4th-year students at Kasr Al-Aini Medical School 🩺📚. She also delivers postgraduate lectures and supervises master’s and MD theses. Beyond academics, Dr. Fayed manages extracurricular activities for undergraduate students, fostering engagement and growth 🌟. Her commitment to education and mentorship has made her a vital contributor to both the academic and personal development of her students 👩‍⚕️✨.

Conferences, Courses & workshops

Dr. Nermin Fayed has actively contributed to various forensic medicine and clinical toxicology conferences, including organizing the Cairo University Annual Conference on “New Challenges in Forensic Sciences” (Jan 19, 2023) 🏛️ and attending the Ain Shams University conference on AI in Forensics (Feb 26, 2023) 🤖. She participated in the Menoufia University Conference (Mar 9, 2023) and webinars on aluminum phosphide poisoning (Mar 20, 2023) and post-submission publishing strategies (Sept 27, 2022) 📚. A speaker at the 7th Forensic Summer School (2016), Dr. Fayed presented on video games and violence 🎮. She also supervised MD protocols (2020-2023) and presented research at IALFS (2017). ✍️

Research Focus

Dr. Nermin Fayed focuses on nanotechnology in biomedical research, particularly its impact on oxidative stress and structural changes in biological systems. Her work explores how gold nanoparticles induce structural alterations and oxidative stress in the lens of the eye, contributing to understanding nanoparticle toxicity and its implications for vision-related diseases. Dr. Fayed’s research bridges nanomedicine and ophthalmology, shedding light on the molecular mechanisms of nanoparticle interactions with biological tissues. This multidisciplinary approach aims to improve nanoparticle safety for biomedical applications. 🌟🔬👁️⚗️

Publication Top Notes

Gold nanoparticles and induction of structural alteration and enhanced oxidative stress in rat lens

Pei Liu | Herbal Medicine and Nutraceuticals | Best Researcher Award

Pei Liu | Herbal Medicine and Nutraceuticals | Best Researcher Award 

Dr Pei Liu, Nanjing University of Chinese Medicine, China

Dr. Pei Liu specializes in exploring the chemical composition and pharmacological efficacy of traditional Chinese medicine (TCM) 🌿. His research focuses on active compounds in classical TCM formulas and the quality mechanisms of authentic medicinal materials. He has led over 10 prestigious projects, including funding from the National Natural Science Foundation of China. 🎖️ Recognized as a top talent under Jiangsu Province’s “Six Top Talents” and “Blue Project,” Dr. Liu has received multiple awards, including First Prizes for Natural Science and TCM Science. 🏆 With 30+ impactful papers and 8 patents, his contributions to TCM are groundbreaking. ✨

Publication Profile

google scholar

Education Qualification

Dr. Pei Liu has achieved remarkable academic and professional recognition 🎓🌟. She was selected as a high-level talent development candidate in the prestigious “Six Top Talents” Program of Jiangsu Province 🏆, showcasing her exceptional expertise and dedication. Additionally, she was honored as an Outstanding Young Faculty under the renowned “Blue Project” of Jiangsu Province Higher Education 📘✨. These accolades highlight her significant contributions to her field and her commitment to advancing education and research. Dr. Liu’s accomplishments reflect her unwavering passion for excellence and her ability to inspire others through her outstanding achievements 🌟💡.

Research Funding and Projects

Dr. Pei Liu has successfully led more than 10 prestigious research projects, showcasing exceptional expertise and dedication. 🌟 These projects include funding from the National Natural Science Foundation of China, a recognition of her impactful contributions to scientific advancement. 🧬 Additionally, she was awarded the Jiangsu Provincial Natural Science Foundation’s Excellent Young Scholars Fund, reflecting her remarkable academic achievements. 📚 Her leadership extended to the Major Basic Research Plan of Jiangsu Provincial Higher Education, emphasizing her commitment to groundbreaking research and education. 🏆 Dr. Liu’s work continues to inspire and drive innovation in her field, setting a high standard for excellence. 🚀

Awards and Honors

Dr. Pei Liu has achieved remarkable recognition for his contributions to science and medicine. 🌟 He was honored with the prestigious First Prize of the Ministry of Education Natural Science Award for his groundbreaking research. 🏆 His dedication to advancing Traditional Chinese Medicine was acknowledged with the First Prize from the Chinese Association of Traditional Chinese Medicine Science and Technology Award. 🌿 Additionally, Dr. Liu received the Second Prize in the National Agricultural and Rural Development Harvest Award (2016-2018) for his impactful work in agriculture and rural development. 🌾 These accolades highlight his excellence and influence across multiple disciplines. 🚀

Research Interests

Dr. Pei Liu’s research revolves around unraveling the secrets of traditional Chinese medicine (TCM) 🌿. His work delves into the chemical composition and efficacy of TCM resources and formulations. He focuses on exploring the active compounds and pharmacological foundations of classical TCM formulas, emphasizing the pairing of herbs and their synergistic medicinal effects 🔬. Additionally, he investigates the mechanisms behind the formation of high-quality authentic medicinal materials, aiming to enhance their therapeutic potential 💊. Dr. Liu’s innovative research bridges ancient wisdom with modern science, contributing significantly to the understanding and development of TCM 🌏.

Research Focus

Dr. Pei Liu’s research primarily focuses on pharmacology 🧪, traditional Chinese medicine 🌿, and network pharmacology 🔬. Her work explores the therapeutic applications of herbal medicines like Salvia miltiorrhiza (Danshen) ❤️ for cardiovascular health, the mechanisms of herbal decoctions 🧬 in treating primary dysmenorrhea, and innovative approaches such as metabolomics and UPLC-MS techniques to analyze bioactive compounds 🩸. Dr. Liu also investigates herb-herb interactions and their pharmacokinetics 📈, enhancing drug efficacy and safety. Her contributions bridge modern scientific methods with traditional remedies, promoting integrated approaches to drug discovery and development.

Publication Top Notes

Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics

Bone tissue engineering in the treatment of bone defects

Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study

A network pharmacology approach to investigate the blood enriching mechanism of Danggui buxue Decoction

Potential of essential oils as penetration enhancers for transdermal administration of ibuprofen to treat dysmenorrhoea

Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathway

Development of essential oils as skin permeation enhancers: Penetration enhancement effect and mechanism of action

Comparative metabolomics analysis on hematopoietic functions of herb pair Gui-Xiong by ultra-high-performance liquid chromatography coupled to quadrupole time-of-flight mass …

Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Dr Shanthi Veerappapillai, Vellore Institute of Technology, India

Dr. Shanthi Veerappapillai is a distinguished Professor at VIT University, specializing in Bioinformatics and Computational Biology. With a Ph.D. from VIT, her research interests include computational protein analysis, drug resistance studies, and virtual screening, particularly focusing on infectious diseases like HIV and tuberculosis. She has led multiple funded research projects and published over 130 peer-reviewed articles. Dr. Veerappapillai has been recognized with awards like the Women Achiever Award for Sponsored Research Excellence (2020) and has supervised numerous Ph.D. graduates. Her dedication to education and research is also reflected in her active participation in conferences and professional societies. 👩‍🔬📚💻🌍

Publication Profile

Google Scholar

Education Qualification

Dr. Shanthi Veerappapillai holds a Ph.D. in Bioinformatics from VIT University, Tamil Nadu, India, and an M.Tech in Chemical Process and Design from SASTRA University, Tamil Nadu, India. She also earned a B.Tech in Chemical Engineering from EGS Pillai Engineering College, Bharathidasan University, Tamil Nadu, India. With a strong foundation in both chemical engineering and bioinformatics, Dr. Veerappapillai brings a multidisciplinary approach to her research and academic work. Her diverse academic background equips her with the expertise to bridge the gap between technology and biology, contributing to advancements in various scientific fields. 🧬⚙️🎓

Leadership in Research

Dr. Shanthi Veerappapillai is a dedicated scientist with extensive leadership experience as Principal Investigator (PI) in multiple prominent projects. Her research spans critical areas such as drug repurposing strategies and cancer research, showcasing her expertise in advancing both medical and computational biology. Through her work, she has contributed significantly to the development of innovative therapeutic approaches, emphasizing her commitment to enhancing healthcare and medical research. Her ability to lead and collaborate on large-scale projects underscores her impact in the field, making her a valuable asset in shaping the future of medical science and computational biology. 🧬🔬💊

Mentorship and Teaching

Dr. Shanthi Veerappapillai is a distinguished academic with vast experience in supervising successful Ph.D. candidates and teaching specialized subjects in biotechnology and bioinformatics. Her dedication to fostering academic development is evident in her role as a mentor to future researchers. With a passion for guiding students through advanced research topics, she has contributed significantly to shaping the next generation of experts in her field. Her work in biotechnology and bioinformatics continues to inspire students, encouraging innovation and critical thinking in these dynamic disciplines. 👩‍🔬📚🎓🔬👩‍💻

Community Engagement

Dr. Shanthi Veerappapillai is a dedicated academician who has made significant contributions to the scientific community through her active involvement in organizing conferences and workshops. As a member of various professional bodies, Dr. Veerappapillai continuously strengthens her presence in the academic world, sharing her expertise and collaborating with fellow researchers. Her commitment to advancing knowledge and fostering professional connections has had a lasting impact on her field. With a focus on promoting growth in the academic and scientific community, Dr. Veerappapillai’s efforts continue to inspire others. 🌍🧑‍🏫📚

Awards and Achievement

Dr. Shanthi Veerappapillai is a distinguished researcher with 131 peer-reviewed journal articles and an H-index of 14. She received the Best Chapter Award from BRSI-VIT for her exceptional contributions in 2023. She was honored with the Women Achiever Award for Sponsored Research Excellence in 2020 and has been a Research Fellow at INTI International University, Malaysia since June 2023. Dr. Veerappapillai’s academic journey includes producing 100% results in Chemical Engineering Thermodynamics courses and securing university ranks and prizes for academic excellence. She has also received several accolades, including a Best Poster Presentation Award at VIT University. 🏆📚👩‍🔬🌟

Research Focus

Dr. V. Shanthi’s research primarily focuses on molecular simulation, bioinformatics, and computational approaches to drug discovery. She has explored mechanisms of drug resistance, particularly in influenza virus neuraminidase, using molecular simulations to understand oseltamivir resistance. Her work also spans polypharmacology, investigating therapeutic agents for non-small cell lung cancer, and the identification of potential inhibitors for various viruses like H5N1. Additionally, she has contributed to bioprocess industry applications, drug repurposing, and plant-based therapeutic compounds. Her research aims at enhancing drug design, discovering novel therapeutic agents, and understanding the molecular interactions that govern drug efficacy. 🔬💊🦠💡

Publication Top Notes

Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach

Current progress and future perspectives of polypharmacology: From the view of non-small cell lung cancer

Bioactive Amento flavone isolated from Cassia fistula L. leaves exhibits therapeutic efficacy

Application of heat exchangers in bioprocess industry: a review

Multi-dimensional screening strategy for drug repurposing with statistical framework—a new road to influenza drug discovery

Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach

Role of the cation-π interaction in therapeutic proteins: A comparative study with conventional stabilizing forces

 

 

 

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Prof Yilong Wang, Beijing Tiantan Hospital, Capital Medical University, China

Dr. Yilong Wang, Executive Vice President of Beijing Tiantan Hospital, Capital Medical University, is a distinguished neurologist and scientist. With an MD and PhD in Neurology, he has pioneered research in stroke and rare neurological disorders. Author of 301 impactful journal articles and holder of 12 patents, his innovative work spans drug delivery systems and precision medicine. Honored with the 2023 Paul Dudley White International Award, he has also authored several clinical neurology manuals. His cutting-edge contributions, including transcranial drug delivery devices, underscore his commitment to advancing global healthcare. 🌍📚

Publication Profile

google scholar

Academic and Professional Background

Professor Yilong Wang 🎓, an accomplished neurologist, earned his MBBS and MSc from North China University of Science and Technology, followed by an MD and PhD in Neurology from Capital Medical University. He completed postdoctoral training at the University of San Francisco 🌉. Currently serving as Executive Vice President and Chief Scientist at Beijing Tiantan Hospital 🏥, Prof. Wang has led groundbreaking research in stroke and rare neurological diseases 🧠. Over the past five years, he has published 72 high-impact papers 📄, holds 12 patents, and made significant strides in precision medicine and drug delivery systems 💊, earning prestigious accolades like the 2023 Paul Dudley White International Award 🏆.

Editorial Appointments

 Professor Yilong Wang 🧑‍⚕️ holds prominent editorial roles, serving as the Assistant Editor-in-Chief of Stroke & Vascular Neurology 📚, Deputy Editor-in-Chief of the Chinese Journal of Cerebrovascular Diseases 🧠, and as an editorial board member of the Chinese Journal of Stroke ✍️. His collaborative efforts extend to leading institutions, including the Frontier Medical Interdisciplinary and Translational Center at the National Center for Neurological Disorders 🌐 and the Beijing Brain Science and Brain-Inspired Research Center 🧬. These partnerships underscore his commitment to advancing neurological research and fostering innovation in cerebrovascular and brain science 🏥.

Professional Memberships

Professor Yilong Wang 🧑‍⚕️ plays key leadership roles in various prestigious organizations. He serves as Vice Chairman of the Expert Committee for the National Health Commission’s Million Disability Reduction Project 🌟, demonstrating his dedication to public health. Prof. Wang is also the Deputy Leader of the Youth Group of the 8th Committee of the Neurology Branch of the Chinese Medical Association 🧠. Additionally, he is the Executive Vice Chairman of the Youth Working Committee of the Chinese Stroke Association 💼 and Vice Chairman of the Cerebral Small Vessel Disease Branch of the Chinese Stroke Association 🩺, driving innovation in neurological care.

Areas of Research

Professor Yilong Wang 🧑‍⚕️ specializes in clinical and translational research on cerebrovascular diseases and rare neurological disorders 🧠, with a focus on interdisciplinary medical-engineering innovations ⚙️. His research includes precision medicine for ischemic stroke 🩺, developing technologies for accurate diagnosis and treatment. He pioneers innovative drug delivery systems 💊, utilizing skull bone marrow-dura-lymphatic pathways to bypass the blood-brain barrier for safe intracranial drug delivery. Prof. Wang also investigates the pathogenesis, diagnostics, and interventions for cerebral small vessel disease and rare neurological disorders 🌐. Additionally, he advances intelligent skull flaps, smart drug delivery systems, and brain-computer interfaces 🤖.

Contributions

Professor Yilong Wang 🧑‍⚕️, a renowned neurologist at Beijing Tiantan Hospital 🏥, has revolutionized stroke and rare neurological disease research 🧠. Over the past five years, he has published 72 high-impact papers in top journals like NEJM, JAMA, and BMJ 📄 and holds 12 patents, with 2 successfully translated into clinical applications 🌟. His innovations include extending the time window for dual antiplatelet therapy, developing drugs for microcirculation disorders, and pioneering skull-based drug delivery systems to bypass the blood-brain barrier 💊. Recipient of the 2023 Paul Dudley White International Award 🏆, Prof. Wang has advanced precision medicine and rare disease research, improving global patient care 🌍.

Research Focus

Professor Yilong Wang is a distinguished researcher focusing on neurology, particularly stroke epidemiology, prevention, and management, and the application of artificial intelligence (AI) in healthcare. His work spans from analyzing stroke prevalence in China to exploring treatment strategies, including antiplatelet therapies and real-world applications of AI in medical practice. With a robust emphasis on stroke prevention, outcomes, and treatment innovation, his contributions bridge advanced research and clinical practice. Wang’s research also addresses the broader implications of healthcare technologies, underscoring their transformative potential. 🧠💊📊

Publication Top Notes

Artificial intelligence in healthcare: past, present and future

Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack

Stroke in China: advances and challenges in epidemiology, prevention, and management

Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic

Rivaroxaban for stroke prevention after embolic stroke of undetermined source

Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study

Summer soil drying exacerbated by earlier spring greening of northern vegetation

 

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Dr Ayaz Ahmed, ICCBS – University of Karachi, Pakistan

Dr. Ayaz Ahmed 🧬🔬 is a Principal Investigator and Assistant Professor at the Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi, Pakistan. With a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China, and an M.Sc. in Microbiology from the University of Karachi, his research focuses on microbial profiling, anti-biofilm agents, and infectious disease models. Dr. Ahmed has supervised numerous postgraduate students and received multiple international awards, including recognition from the American Society for Microbiology and Bill & Melinda Gates Foundation. He also leads funded projects on combating antibiotic-resistant pathogens. 🌟

Publication Profile

google scholar

Qualifications

Dr. Ayaz Ahmed holds a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China (2012), and a Master’s in Microbiology from the University of Karachi, Pakistan (2006, First Division). 🧬🎓 His doctoral research focused on the “Microbial profiling of dental plaque/Biofilm from dental caries and periodontitis patients” and explored the effects of Lactobacillus species on S. mutans biofilm formation. 🦷🔬 With a strong academic foundation and research expertise in microbiology and molecular biology, Dr. Ayaz contributes significantly to the understanding of microbial interactions in dental health and disease. 🌟

Job Responsibilities

Dr. Ayaz Ahmed is a Principal Investigator at the Cell Biology Lab, where he oversees the Imaging Facility, maintaining high-end fluorescence and light microscopes. He supports students by assisting them in acquiring high-quality images for their theses and manuscripts. Dr. Ahmed also manages the National Animal Facility for Laboratory Animal Research and Care. He supervises routine animal house operations and collaborates with a veterinary doctor to maintain SPF rats, mice, and hamsters. He is responsible for establishing models for infectious diseases and memory deficits to evaluate the efficacy of natural compounds. Dr. Ahmed also conducts toxicological studies and trains students in ethical animal research practices. 🧬🔬🐁

Student Supervised

Dr. Ayaz Ahmed and his team of dedicated researchers have made significant strides in their exploration of innovative therapeutic strategies. Among the Ph.D. candidates, Zulfiqar Ahmed’s research on controlling salmonellosis through probiotics in poultry, Binte Zehra’s study on modulating the metastatic potential of NSCLC, and Jazib Shafiq’s investigation into gut dysbiosis and anxiety have all been awarded. Additionally, Afshan Shams, Yamina Usmani, and Shariqa Khuwaja are examining the potential of natural and synthetic compounds in combating oral cancer and other diseases. Several M. Phil. students are also contributing to research on antimicrobial resistance and cancer therapies. 🧪🔬🧫

Honors and Awards

Dr. Ayaz Ahmed has earned numerous accolades throughout his distinguished career. In 2024, he received the Award for Collaborative Scientific Achievement from the Institute of Food Science and Technology, Chinese Academy of Agriculture Science, Beijing. He also became an International Federation for Biosafety Association (IFBA) Certified Biological Waste Management Professional and Bio-risk Management Professional in 2023. Dr. Ahmed was selected as a Mentor for the ASM Future Leaders Mentoring Fellowship Program in 2023 and was awarded the Health Security Partner Grant by the Bill & Melinda Gates Foundation in 2021. He has also earned prestigious travel awards and fellowships, including the American Society for Microbiology ID Fellowship and the Science and Technology Talent Award. 🏅🌍🦠

Completed Projects

Dr. Ayaz Ahmed has led multiple impactful research projects focused on combating multidrug-resistant microorganisms and improving public health. His research on the effect of synthetic and natural compounds on biofilm formation was funded by the Higher Education Commission of Pakistan (HEC) under project # HEC No: PD-IPFP/HRD/HEC/ 2013/1182. He also contributed to projects such as Personal Protective Equipment for Sindh Poultry Vaccine Center (funded by CRDF Global, USA), and oral pathogens related to dental caries (funded by ICCBS). Notably, his work on antimicrobial-resistant water contaminants, funded by the U.S.-Pakistan Centers for Advanced Studies in Water, aims to improve water quality. He further advanced research on antimicrobial and antibiofilm agents targeting Acinetobacter baumannii and Klebsiella pneumonia with funding from HEC. 💧🔬🦠

Professional Experience

Dr. Ayaz Ahmed has had a distinguished career in academia and research. Since June 2017, he has been serving as an Assistant Professor at the International Center for Chemical and Biological Sciences, University of Karachi. Prior to this, he worked as a Senior Research Officer at the same institution from November 2013 to June 2017. Dr. Ahmed also pursued Post-Doctoral training in Behavioral Sciences at Hunan Drug Safety Evaluation in Changsha, China, from January 2016 to February 2017. His earlier roles include Assistant Professor on Interim Placement, Research Officer in Avian Influenza Vaccine Production, and a research intern in the National Internship Program. 🧪📚

Professional Membership

Dr. Ayaz Ahmed is an active member of several prestigious professional organizations, contributing significantly to the fields of microbiology and infectious diseases. His memberships include the American Society for Microbiology (ASM) 🦠, the Pakistan Biological Safety Association (PBSA) 🧫, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 🌍. Additionally, he is a member of the American Association of Cancer Research (AACR) 🎗️ and the Medical Microbiology & Infectious Disease Society of Pakistan (MMIDSP) 🇵🇰. These memberships reflect his commitment to advancing research and innovation in microbiology, infectious diseases, and cancer research.

Research Focus

Dr. Ayaz Ayaz Ahmed research focus primarily revolves around microbiology, particularly in the fields of gut microbiota analysis, antimicrobial resistance, and biofilm formation. His studies often investigate the interactions between microorganisms and the human or animal host, such as comparing gut microbe profiles between healthy individuals and those with conditions like hyperthyroidism and liver cirrhosis. Additionally, Dr. Ahmed explores innovative therapeutic approaches, including the development of antimicrobial agents, such as nanoparticles conjugated with antibiotics to combat biofilm-forming pathogens like Klebsiella pneumoniae and Staphylococcus aureus. His work has significant implications for medical microbiology and the treatment of infectious diseases. 🦠🔬

Publication Top Notes

Gut microbe analysis between hyperthyroid and healthy individuals

Phylogenetic and biological characterization of Newcastle disease virus isolates from Pakistan

Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae

Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals

Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae

Effect of Lactobacillus species on Streptococcus mutans biofilm formation.

Comparison of oral microbiota in orthodontic patients and healthy individuals

Synthesis and Chemosensing of Nitrofurazone using Olive oil based Silver Nanoparticles (O-AgNPs)

Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds

Sajid Ali | Nanomedicine | Excellence in Research

Sajid Ali | Nanomedicine | Excellence in Research

Dr Sajid Ali, Quaid I azam university Islamabad, Pakistan

Dr. Sajid Ali, a dedicated pharmacist from Pakistan, holds a PharmD (CGPA 3.8/4) and an MPhil in Pharmaceutics (CGPA 3.9) from Quaid-i-Azam University, Islamabad. With experience as a lab demonstrator and pharmacist, he excels in pharmaceutical sciences, including HPLC, UV spectroscopy, and GMP implementation. Dr. Ali’s research on green-synthesized zinc oxide nanoparticles for wound management was published in Microbial Pathogenesis. Passionate about global healthcare, he has also completed numerous certifications, including antimicrobial resistance and pharmaceutical innovations. Dr. Ali’s multilingual abilities, extracurricular contributions, and drive for innovation position him as a transformative force in healthcare. 💊🌍

Education

Dr. Sajid Ali is currently pursuing an MPhil in Pharmaceutics at Quaid-i-Azam University, Islamabad 🏛️, a prestigious institution known for its excellence in research and education 🌟. He began this advanced academic journey on September 1, 2023, and continues to deepen his expertise in the field of pharmaceutics 💊. Previously, Dr. Sajid completed his Doctor of Pharmacy (Pharm.D) degree at the same university 🎓, spanning from September 2018 to September 2023. With a strong foundation in pharmacy and a passion for innovation in healthcare 🌱, Dr. Sajid aspires to make significant contributions to the pharmaceutical sciences. 🌟

Work Experience

Dr. Sajid Ali, a dedicated pharmacist from Pakistan 🎓🇵🇰, has a robust professional journey spanning academia, community pharmacy, and industry. As a Lab Demonstrator at Quaid-i-Azam University (Sept 2024–Mar 2025) 📚🧪, he guided students in using advanced pharmaceutical instruments like HPLC and FTIR while honing their analytical skills. Currently, as a Pharmacist at Al Shifa Pharmacy in Rawalpindi (Sept 2024–Present) 💊👩‍⚕️, he ensures accurate medication dispensing, patient counseling, and inventory management. His prior role as an Industrial Pharmacist at Glitz Pharmaceutical (July–Aug 2023) 🏭🔬 focused on R&D, quality control, and GMP compliance. Sajid’s journey began at Siddique Homeo Clinic (2018–2022) 🌿🤝, where he excelled in patient counseling and multitasking.

Online Courses

Dr. Sajid Ali has an impressive record of completing various online courses, showcasing his dedication to continuous learning 🌟. He gained expertise in International Business through a course at the University of New Mexico, covering exporting goods, joint ventures, and branch distribution 🌍. During the pandemic, he enriched his knowledge with COVID-19 – A Clinical Update from the University of Florida 🦠. Dr. Ali also explored Cancer Biology at Johns Hopkins University 🔬, clinical terminology at the University of Pittsburgh 🏥, and Pharmaceutical Innovations at the University of Minnesota 💊. Additionally, he completed an Antimicrobial Resistance course at the Technical University of Denmark 🧪.

Volunteer Experience

Dr. Sajid Ali has been actively contributing to the Pakistan Polio Eradication Programme under WHO, conducting numerous Lot Quality Assurance Sampling (LQAS) during the August 2023 National Immunization Day (NID) campaign 📊. He collected vital household data through handheld devices in targeted areas of Rawalpindi, ensuring data accuracy and quality 🔍. Additionally, Dr. Sajid received a prestigious certificate in Quality Considerations for Aseptic Processing from the United States Pharmacopoeia Education in December 2022 🧪. He also earned a certificate for participating in the Chinese Bridge: Travel with Tang Poetry online program, fostering cross-cultural learning, sponsored by China’s Ministry of Education 🌏📜.

Research Focus

Dr. Sajid Ali focuses on nanotechnology in biomedical applications, particularly in developing green-synthesized nanoparticles for wound management. His research bridges nanotechnology 🧪, drug delivery systems 💊, and antimicrobial therapies 🦠 to improve healing processes 🩹. By utilizing environmentally friendly methods 🌱, Dr. Ali innovates solutions for antibiotic delivery and enhanced tissue repair. His work contributes to sustainable medical technologies, showcasing a dual impact on infection control and wound care. Dr. Ali’s groundbreaking research highlights the intersection of nanomedicine and green chemistry, fostering advancements in healthcare innovation 🚑.

Publication Top Notes

Harnessing Green Synthesized Zinc Oxide Nanoparticles for Dual Action in Wound Management: Antibiotic Delivery and Healing Promotion

Claudia Omes | Clinical Trials | Best Researcher Award

Claudia Omes | Clinical Trials | Best Researcher Award

Dr Claudia Omes, Fondazione IRCCS Policlinico San Matteo, Italy

Dr. Claudia Omes is a distinguished biologist specializing in reproductive medicine, embryology, and stem cell research. She holds multiple degrees from the University of Pavia and Milan, including a Ph.D. in Bioengineering and Bioinformatics. Dr. Omes is the Head Biologist and Lab Director at the Center for Reproductive Medicine at Policlinico “San Matteo,” Pavia, and a Contract Professor at the University of Pavia. She has contributed to pioneering research in cryopreservation, semen analysis, and stem cell biology, with multiple publications in top journals. She is an active member of ESHRE and SIERR. 🧬🔬👩‍🔬📚

Publication Profile

Orcid

Qualifications and Certifications

Dr. Claudia Omes is a distinguished expert in bioengineering and bioinformatics, holding a Ph.D. in the field, along with a Postgraduate degree in Microbiology and Virology, both achieved with high honors 🎓. She also holds multiple specialized certifications, including ISO 9001:2008 Certified Auditor in Public Health 🏅 and certifications in clinical embryology and semen analysis 🧬. Her expertise spans across bioengineering, public health, and clinical research, making her a prominent figure in the scientific community. Dr. Omes’ comprehensive academic background and specialized certifications highlight her commitment to advancing healthcare and biotechnology. 🌿💡

Research Experience

Dr. Claudia Omes is the Head Biologist and Lab Director at the Center for Reproductive Medicine of Fondazione I.R.C.C.S. Policlinico “San Matteo.” Her pioneering work in human reproduction and embryology has significantly advanced the field. She specializes in cryopreservation of spermatozoa, oocytes, and embryos, as well as in stem cell research and bone tissue engineering. Through her dedication and expertise, Dr. Omes has made notable contributions to reproductive medicine, with a focus on improving fertility treatments and tissue regeneration. Her work continues to shape the future of reproductive science. 🧬🔬🍼👩‍🔬

Awards and Recognition

Dr. Claudia Omes has earned significant recognition in the scientific community. She was awarded the Best Oral Communication in the Biological Field at the II FISSR conference in Riccione (May 24-26, 2012) 🏅. In 2011, she received the GIC Study Award from the Italian Society of Cytometry at the XXIX National Conference of Cytometry in Salerno 🎖️. Dr. Omes was also honored with the Best Poster award at the 62nd National Congress of SIAI in Verona (September 14-16, 2008) 🎨. These accomplishments showcase her excellence in the fields of cytometry and biological sciences 🌱🔬.

Research Focus

Dr. Claudia Omes focuses on reproductive biology and male infertility, exploring factors that impact sperm quality and fertility. Her research investigates the role of infections, inflammation, and biomarkers in male fertility, particularly in infertile and oncological patients. She has contributed to studies on the effects of HPV infections (HPV-51 and HPV-52) on sperm quality, the expression of miRNAs in pre-implantation embryos, and the potential of novel diagnostic approaches like calprotectin to screen for male infertility risk. Additionally, Dr. Omes has studied the effects of cancer-induced inflammation on semen quality and the application of stem cells in reproductive medicine. 🧬👨‍🔬💉

Publication Top Notes